Investigating Accelerated Learning in Healthy Subjects: Trigeminal Nerve Stimulation

Sponsor
The University of Texas at Dallas (Other)
Overall Status
Terminated
CT.gov ID
NCT03138590
Collaborator
(none)
20
1
2
57.7
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate whether it is possible to accelerate learning and improve associative memory performance in healthy subjects, by applying transcranial Direct Current Stimulation (tDCS) targeting the trigeminal nerve during a verbal paired-associate learning task

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS
N/A

Detailed Description

Associative memory refers to remembering the association between two items, such as a face and a name or a word in English and the same word in another language. It is not only important for learning, but it is also one of the first aspects of memory performance that is impacted by aging and by Alzheimer׳s disease. For decades, neuroscientists have investigated associative learning and memory and ways to accelerate and enhance associative learning and memory.

Transcranial Direct Current stimulation (tDCS) is a non-invasive and painless electrical stimulation technique that has demonstrated to accelerate learning and improve memory in some studies. To investigate whether it is possible to accelerate learning and improve associative memory using tDCS, the performance in a Verbal Paired-Associate memory task of 2 groups will be compared. The first group will get active tDCS during the verbal paired-associate learning task. The second group will get sham tDCS during the verbal paired-associate learning task.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
participants will be randomly assigned to one of 2 groups: (1) active tDCS (2) sham tDCSparticipants will be randomly assigned to one of 2 groups: (1) active tDCS (2) sham tDCS
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Investigating Accelerated Learning in Healthy Subjects
Actual Study Start Date :
Apr 4, 2017
Actual Primary Completion Date :
Jan 25, 2022
Actual Study Completion Date :
Jan 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active tDCS

Active transcranial Direct Current Stimulation targeting the trigeminal nerve

Device: Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS
Transcranial Direct Current Stimulation targeting the trigeminal nerve

Sham Comparator: Sham tDCS

Sham transcranial Direct Current Stimulation targeting the trigeminal nerve

Device: Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS
Transcranial Direct Current Stimulation targeting the trigeminal nerve

Outcome Measures

Primary Outcome Measures

  1. Associative Memory Assessed by a Verbal Paired-Associate Test [1 week after stimualtion]

    Changes in performance in the Verbal Paired-Associate memory task is compared between the 2 groups (1. Active tDCS 2. Sham tDCS) to investigate the influence of tDCS on Associative Memory.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Native English Speaker
Exclusion Criteria:
  • History of severe head injuries, epileptic insults, or heart disease.

  • Severe psychiatric disorders and severe untreated medical problems

  • Acquainted with the foreign language used in the learning task

  • Contraindications for tDCS (e.g. pregnant, implanted devices)

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas of Dallas Richardson Texas United States 75080

Sponsors and Collaborators

  • The University of Texas at Dallas

Investigators

  • Principal Investigator: Sven Vanneste, The University of Texas at Dallas

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Sven Vanneste, Associate professor, The University of Texas at Dallas
ClinicalTrials.gov Identifier:
NCT03138590
Other Study ID Numbers:
  • 17-34 TN
First Posted:
May 3, 2017
Last Update Posted:
Feb 3, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Sven Vanneste, Associate professor, The University of Texas at Dallas

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Active tDCS Sham tDCS
Arm/Group Description Active transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve Sham transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve
Period Title: Overall Study
STARTED 10 10
COMPLETED 10 10
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Active tDCS Sham tDCS Total
Arm/Group Description Active transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve Sham transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve Total of all reporting groups
Overall Participants 10 10 20
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
21.5
(4.67)
21.1
(2.33)
21.3
(3.6)
Sex: Female, Male (Count of Participants)
Female
4
40%
9
90%
13
65%
Male
6
60%
1
10%
7
35%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
1
10%
2
20%
3
15%
Not Hispanic or Latino
9
90%
8
80%
17
85%
Unknown or Not Reported
0
0%
0
0%
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
Asian
3
30%
4
40%
7
35%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
Black or African American
4
40%
2
20%
6
30%
White
3
30%
3
30%
6
30%
More than one race
0
0%
0
0%
0
0%
Unknown or Not Reported
0
0%
1
10%
1
5%
Region of Enrollment (Count of Participants)
United States
10
100%
10
100%
20
100%
Beck Depression Inventory Scale (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
5
(5.65)
4.3
(4.34)
4.65
(4.92)
Beck Anxiety Inventory Scale (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
2.6
(2.07)
2.6
(2.99)
2.6
(2.5)
Mini Mental State Examination (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
29.3
(1.06)
29.5
(0.972)
29.4
(0.99)

Outcome Measures

1. Primary Outcome
Title Associative Memory Assessed by a Verbal Paired-Associate Test
Description Changes in performance in the Verbal Paired-Associate memory task is compared between the 2 groups (1. Active tDCS 2. Sham tDCS) to investigate the influence of tDCS on Associative Memory.
Time Frame 1 week after stimualtion

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Active tDCS Sham tDCS
Arm/Group Description Active transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve Sham transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve
Measure Participants 10 10
Mean (Standard Deviation) [percentage of words recalled from V1]
32.9
(16.2)
38.1
(18.6)

Adverse Events

Time Frame One Week
Adverse Event Reporting Description Before the end of the experiment, participants were asked to fill out a questionnaire (Brunoni et al., 2011) to assess their experiences of possible side effects (e.g., headache, neck pain, and scalp pain) related to the stimulation on a 4-point scale (1 = absent, 2 = mild, 3 = moderate, and 4 = severe).
Arm/Group Title Active tDCS Sham tDCS
Arm/Group Description Active transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve Sham transcranial Direct Current Stimulation targeting the trigeminal nerve Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS: Transcranial Direct Current Stimulation targeting the trigeminal nerve
All Cause Mortality
Active tDCS Sham tDCS
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%)
Serious Adverse Events
Active tDCS Sham tDCS
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%)
Other (Not Including Serious) Adverse Events
Active tDCS Sham tDCS
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Sven Vanneste, Principal Investigator
Organization University of Texas at Dallas
Phone 972-883-7277
Email sven.vanneste@utdallas.edu
Responsible Party:
Sven Vanneste, Associate professor, The University of Texas at Dallas
ClinicalTrials.gov Identifier:
NCT03138590
Other Study ID Numbers:
  • 17-34 TN
First Posted:
May 3, 2017
Last Update Posted:
Feb 3, 2022
Last Verified:
Jan 1, 2022